Abstract: The present invention provides a compound of the formula (I) and pharmaceutically acceptable salts having useful antiviral activity against viruses of the herpes family. In said formula, X=O, (CH2)m, S, SO, SO2, NH, NR8 or a chemical bond; Y=O, (CH2)m, S, SO, SO2, NH, NR8; Z=NH, O, NR8, S, SO, SO2. The remaining substituents are described in the specification.

Abstract: A method of printing with an ink jet printer includes providing a printhead having a plurality of first nozzles with a first size and a plurality of second nozzles with a second size larger than the first size. The first nozzles and the second nozzles are alternatingly disposed in a vertical direction. Print data corresponding to first columns of pixel locations is provided. The print data includes for each pixel location in the first columns both a respective large dot print datum and a respective small dot print datum. One of the respective large dot print datum and the respective small dot print datum is printed at a first pixel location of the corresponding pixel locations in the first columns. Second columns of pixel locations interleaved with the first columns of pixel locations are provided.

Abstract: A print medium is printed on with a printhead of an ink jet printer. The print medium is advanced in an advance direction a predetermined amount. The print medium is printed on with the printhead in an area corresponding to the predetermined amount. A determination is made of an end of printable area on the print medium in the advance direction. The print medium is advanced in the advance direction a minimum reliable move amount, dependent upon the end of printable area determination, The minimum reliable move amount is less than the predetermined amount. The print medium is printed on with the printhead in an area corresponding to the minimum reliable move amount.

Abstract: The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4).

Abstract: A method of printing with an ink jet printer includes providing a printhead having a plurality of first nozzles with a first size and a plurality of second nozzles with a second size larger than the first size. The first nozzles and the second nozzles are alternatingly disposed in a vertical direction. Print data corresponding to first columns of pixel locations is provided. The print data includes for each pixel location in the first columns both a respective large dot print datum and a respective small dot print datum. One of the respective large dot print datum and the respective small dot print datum is printed at a first pixel location of the corresponding pixel locations in the first columns. Second columns of pixel locations interleaved with the first columns of pixel locations are provided.

Abstract: 1

Abstract: Disclosed are compounds of the formula (I) wherein: R2, R7, RI3, R14 and R15 are independently hydrogen, or (un)substituted lower alkyl, (un)substitued lower alkenyl, (un)substituted lower alkynyl, or (un)substituted —(CH2)nR12; R5 is halogen, cyano, nitro, —R9, —NR9R10, or —OR9; R6 is halogen, cyano, nitro, —R9, —NR9R10, —OR9, —Co2R9, —COR9, —CONR9R10, —NR9COR10, (un)substiuted lower alkenyl, or (un)substituted lower alkynyl; R8 is —CO2R13, —COR13, —CONR13R14, —CSNR13R14, —C(NR13)NR14R15, —SO3R13, —SO2R13, —SO2NR13R14, —PO3R13R14, —POR13R14, —PO(NR13R14)2; R9 and R10 are independently hydrogen or (un)substituted lower alkyl; R11 is a heteroaryl or a heterocyclic group; R12 is a cycloalkyl, a heterocyclic, an aryl, or a heteroaryl group; and n is 0,1,2, or 3.

Abstract: A patient monitor has a plurality of voice alarm messages stored in a memory. When the monitor detects an occurrence of an alarm condition, such as an usual physiological characteristic of the patient, a voice alarm message associated with that condition is played back through a loudspeaker. To enable the patient monitor to be used throughout the world, the end user is able to replace each of the prerecorded voice alarm messages. Thus the end user is able to store voice messages in the native language and dialect spoken where the monitor is used.

Abstract: A patient monitor has a plurality of voice alarm messages stored in a memory. When the monitor detects an occurrence of an alarm condition, such as an usual physiological characteristic of the patient, a voice alarm message associated with that condition is played back through a loudspeaker. To enable the patient monitor to be used throughout the world, the end user is able to replace each of the prerecorded voice alarm messages. Thus the end user is able to store voice messages in the native language and dialect spoken where the monitor is used.

Abstract: A communication system includes an optical transmission network having an input end and an output end. A wavelength division multiplexer coupled to the input end of the optical transmission network receives data packets directly from each internet-traffic source and modulates, in response to those data packets, a corresponding optical beam having a selected wavelength. At the other end of the optical transmission network, a wavelength division demultiplexer is configured to select a particular optical beam corresponding to each internet-traffic source and to retrieve the data packets placed thereon by the wavelength division multiplexer.

Abstract: This invention relates to an amplifier having digital micro-processor control apparatus and, in particular, to a high frequency power amplifier that includes a micro-processor control system to accurately regulate the operating point of the various amplifying elements in the high frequency power amplifier. The basic amplifier circuitry consists of a micro-controller, a variable voltage attenuator (VVA), a digital to analogue converter and an EEPROM. The EEPROM provides a lookup table which is read by the micro-controller, which then writes to the digital to analogue converter to set the control voltage to the variable voltage attenuator.

Abstract: The present invention provides compounds having the Formula I 1

Abstract: Aryl alkenamides derivatives of Formula I or a pharmaceutically acceptable salt thereof are novel MCP-1 antagonists and are thus useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection where V═O,S, NH or a bond; Ar can be unsubstituted or substituted benzimidazole, phenyl, biphenyl, pyridyl, naphthyl, quinoline or isoquinoline. The other meanings for the terms are recited in the specification below.

Abstract: Benzenesulfonamides of formula (I), in which W is OR1, NR2OR1, NRARB, NR2NRARB, or NR2(CH2)2-4NRARB and the other variables as defined in the claims, are inhibitors of MEK and are effective in the treatment of proliferative diseases, cancer, stroke, heart failure, xenograft rejection, arthritis, cystic fibrosis, hepatomegaly, cardiomegaly, Alzheimer's disease, complications of diabetes, septic shock, and viral infection.

Abstract: This invention relates to an amplifier having digital micro-processor control apparatus and, in particular, to a high frequency power amplifier that includes a micro-processor control system to accurately regulate the operating point of the various amplifying elements in the high frequency power amplifier. The basic amplifier circuitry consists of a micro-controller, a variable voltage attenuator (VVA), a digital to analogue converter and an EEPROM. The EEPROM provides a lookup table which is read by the micro-controller, which then writes to the digital to analogue converter to set the control voltage to the variable voltage attenuator.

Abstract: The present invention provides compounds that block calcium channels having the Formula I shown below. The present invention also provides methods of using the compounds of Formula I to treat stroke, cerebral ischemia, head trauma, or epilepsy and to pharmaceutical compositions that contain the compounds of Formula I.

Abstract: Aryl alkenamides derivatives of Formula I or a pharmaceutically acceptable salt thereof are novel MCP-1 antagonists and are thus useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection 1

Abstract: An ink jet printer receives image data defining a pattern of dots in a non-square rectangular grid and prints the pattern of dots on a print medium based on the image data. The pattern of dots consists of at least four interlaced checkerboard arrays of dots printed in four passes of the print head across the print medium, where each one of the four checkerboard arrays is printed during a different one of the four passes. Each of the checkerboard arrays is offset from the other checkerboard arrays by a predetermined spacing in at least one of the first and second directions. The printer prints the second checkerboard array horizontally offset from the first checkerboard array by a distance substantially equivalent to {fraction (5d/4)}, where d is the diameter of the printed dots.

Abstract: A thermal ink jet printer has two columns of nozzles in its nozzle plate parallel to the direction of motion of each sheet of media. When the sheet of media is thin such as bond paper having a thickness of 0.1 mm, for example, all of the nozzles are available for printing. When the sheet of media is thick such as an envelope having a thickness of 0.5 mm, for example, one-fourth of the nozzles are available for printing, and these are the nozzles first passed by the sheet of media during its advancement. Each sheet of media has the same feed rate although it takes four times as long for the thick sheet of media to be printed.

Abstract: A method of printing on a print medium with an ink jet printer uses a first color ink, a second color ink and a black ink. An image area on the print medium has a plurality of pixel locations. Print image data indicate one of a presence and an absence of the first color ink, the second color ink and the black ink at the plurality of pixel locations. A subset of the print image data is defined. A determination is made as to whether the subset of print image data indicates 1) a presence of the first color ink and/or the second color ink within the subset and a presence of the black ink within the subset; 2) a presence of each of the first color ink and the second color ink within the subset at a same corresponding pixel location; and/or 3) a presence of the first color ink and/or the second color ink within the subset at a number of corresponding pixel locations exceeding a threshold value. The print medium is printed on in the image area at an interlace level which is dependent upon the determination.